Total Payments
$1,867
2024 Payments
$49.14
Companies
7
Transactions
15

Payment Breakdown by Category

Other$1,125 (60.3%)
Food & Beverage$718.09 (38.5%)
Education$24.12 (1.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Honoraria $1,125 2 60.3%
Food and Beverage $718.09 12 38.5%
Education $24.12 1 1.3%

Top Paying Companies

Company Total Records Latest Year
Zogenix Inc. $1,000 1 $0 (2020)
NEUROPACE, INC. $432.07 3 $0 (2017)
UCB, Inc. $206.86 6 $0 (2024)
Lundbeck LLC $125.00 1 $0 (2017)
Neurelis, Inc. $46.56 2 $0 (2024)
Eisai Inc. $35.19 1 $0 (2017)
Sunovion Pharmaceuticals Inc. $21.53 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $49.14 2 Neurelis, Inc. ($27.97)
2023 $130.02 2 UCB, Inc. ($130.02)
2022 $36.96 2 UCB, Inc. ($36.96)
2021 $37.30 2 UCB, Inc. ($18.71)
2020 $1,000 1 Zogenix Inc. ($1,000)
2018 $21.53 1 Sunovion Pharmaceuticals Inc. ($21.53)
2017 $592.26 5 NEUROPACE, INC. ($432.07)

All Payment Transactions

15 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
07/09/2024 Neurelis, Inc. VALTOCO (Drug) Food and Beverage In-kind items and services $27.97 General
Category: EPILEPSY
01/23/2024 UCB, Inc. Fintepla (Drug) Food and Beverage In-kind items and services $21.17 General
Category: Neurology
10/12/2023 UCB, Inc. Fintepla (Drug) Food and Beverage In-kind items and services $105.65 General
Category: Neurology
02/27/2023 UCB, Inc. Briviact (Drug) Food and Beverage In-kind items and services $24.37 General
Category: Neurology
11/15/2022 UCB, Inc. Briviact (Drug) Food and Beverage In-kind items and services $17.23 General
Category: Neurology
03/15/2022 UCB, Inc. Briviact (Drug) Food and Beverage In-kind items and services $19.73 General
Category: Neurology
12/14/2021 UCB, Inc. Briviact (Drug) Food and Beverage In-kind items and services $18.71 General
Category: Neurology
06/22/2021 Neurelis, Inc. VALTOCO (Drug) Food and Beverage In-kind items and services $18.59 General
Category: EPILEPSY
06/25/2020 Zogenix Inc. Fintepla (Drug) Honoraria Cash or cash equivalent $1,000.00 General
Category: Treatment of seizures
01/10/2018 Sunovion Pharmaceuticals Inc. APTIOM (Drug) Food and Beverage In-kind items and services $21.53 General
Category: CNS
12/03/2017 NEUROPACE, INC. RNS System (Device) Food and Beverage In-kind items and services $165.49 General
Category: Epilepsy
12/03/2017 Eisai Inc. Fycompa (Drug) Food and Beverage Cash or cash equivalent $35.19 General
Category: Neurology
09/16/2017 NEUROPACE, INC. RNS System (Device) Food and Beverage In-kind items and services $242.46 General
Category: Epilepsy
09/16/2017 NEUROPACE, INC. RNS System (Device) Education In-kind items and services $24.12 General
Category: Epilepsy
05/12/2017 Lundbeck LLC SABRIL (Drug) Honoraria Cash or cash equivalent $125.00 General
Category: NEUROLOGY

About Dr. Deepa Sirsi, MD

Dr. Deepa Sirsi, MD is a Neurology with Special Qualifications in Child Neurology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2008. The National Provider Identifier (NPI) number assigned to this provider is 1750548590.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deepa Sirsi, MD has received a total of $1,867 in payments from pharmaceutical and medical device companies, with $49.14 received in 2024. These payments were reported across 15 transactions from 7 companies. The most common payment nature is "Honoraria" ($1,125).

Practice Information

Products in Payments

  • Fintepla (Drug) $1,127
  • RNS System (Device) $432.07
  • SABRIL (Drug) $125.00
  • Briviact (Drug) $80.04
  • VALTOCO (Drug) $46.56
  • Fycompa (Drug) $35.19
  • APTIOM (Drug) $21.53

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology with Special Qualifications in Child Neurology Doctors in Dallas